BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    System, Endovascular Graft, Aortic Aneurysm Treatment

    PMA: P140016 · Decision Sep 15, 2015
    View on FDA
    Classifications
    1
    FEI Numbers
    34
    Registration Numbers
    34

    Basic Information

    Device Name
    System, Endovascular Graft, Aortic Aneurysm Treatment
    Trade Name
    ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT
    PMA Number
    P140016
    Device Class
    FDA Class 3
    Product Code
    MIH
    Generic Name
    SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
    Medical Specialty
    Unknown
    Advisory Committee
    Cardiovascular
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    September 15, 2015
    Date Received
    August 13, 2014
    Expedited Review
    N
    Docket Number
    15M-3377

    Advisory Committee Statement

    APPROVAL FOR THE ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT. THIS DEVICE IS INDICATED FOR THE ENDOVASCULAR TREATMENT OF PATIENTS WITH ISOLATED LESIONS OF THE DESCENDING THORACIC AORTA (NOT INCLUDING DISSECTIONS) HAVING VASCULAR ANATOMY SUITABLE FOR ENDOVASCULAR REPAIR, INCLUDING:1) ILIAC/FEMORAL ANATOMY THAT IS SUITABLE FOR ACCESS WITH THE REQUIRED INTRODUCTION SYSTEMS; AND2) NONANEURYSMAL AORTIC SEGMENTS (FIXATION SITES) PROXIMAL AND DISTAL TO THE THORACIC LESION:A) WITH A LENGTH OF AT LEAST 20 MM; ANDB) WITH A DIAMETER MEASURED OUTER WALL TO OUTER WALL OF NO GREATER THAN 42 MM AND NO LESS THAN 15 MM.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    MIH System, Endovascular Graft, Aortic Aneurysm Treatment